» Articles » PMID: 36175997

The Effect of High-polyphenol Mediterranean Diet on Visceral Adiposity: the DIRECT PLUS Randomized Controlled Trial

Abstract

Background: Mediterranean (MED) diet is a rich source of polyphenols, which benefit adiposity by several mechanisms. We explored the effect of the green-MED diet, twice fortified in dietary polyphenols and lower in red/processed meat, on visceral adipose tissue (VAT).

Methods: In the 18-month Dietary Intervention Randomized Controlled Trial PoLyphenols UnproceSsed (DIRECT-PLUS) weight-loss trial, 294 participants were randomized to (A) healthy dietary guidelines (HDG), (B) MED, or (C) green-MED diets, all combined with physical activity. Both isocaloric MED groups consumed 28 g/day of walnuts (+ 440 mg/day polyphenols). The green-MED group further consumed green tea (3-4 cups/day) and Wolffia globosa (duckweed strain) plant green shake (100 g frozen cubes/day) (+ 800mg/day polyphenols) and reduced red meat intake. We used magnetic resonance imaging (MRI) to quantify the abdominal adipose tissues.

Results: Participants (age = 51 years; 88% men; body mass index = 31.2 kg/m; 29% VAT) had an 89.8% retention rate and 79.3% completed eligible MRIs. While both MED diets reached similar moderate weight (MED: - 2.7%, green-MED: - 3.9%) and waist circumference (MED: - 4.7%, green-MED: - 5.7%) loss, the green-MED dieters doubled the VAT loss (HDG: - 4.2%, MED: - 6.0%, green-MED: - 14.1%; p < 0.05, independent of age, sex, waist circumference, or weight loss). Higher dietary consumption of green tea, walnuts, and Wolffia globosa; lower red meat intake; higher total plasma polyphenols (mainly hippuric acid), and elevated urine urolithin A polyphenol were significantly related to greater VAT loss (p < 0.05, multivariate models).

Conclusions: A green-MED diet, enriched with plant-based polyphenols and lower in red/processed meat, may be a potent intervention to promote visceral adiposity regression.

Trial Registration: ClinicalTrials.gov , NCT03020186.

Citing Articles

Non-invasive vestibular nerve stimulation (VeNS) reduces visceral adipose tissue: results of a randomised controlled trial.

Viirre E, Sittlington J, Wing D, Price R, Logue C, Moreno D Sci Rep. 2025; 15(1):8753.

PMID: 40082596 PMC: 11906803. DOI: 10.1038/s41598-025-92744-9.


Effect of Polyphenol Supplementation on Adiposity: A Systematic Review of Randomized Clinical Trials.

Mendes I, Ribeiro M, de Souza L, Rosa C, Hermsdorff H, Bressan J Curr Nutr Rep. 2025; 14(1):36.

PMID: 39982599 DOI: 10.1007/s13668-025-00626-3.


Visceral adipose tissue area and proportion provide distinct reflections of cardiometabolic outcomes in weight loss; pooled analysis of MRI-assessed CENTRAL and DIRECT PLUS dietary randomized controlled trials.

Klein H, Zelicha H, Meir A, Rinott E, Tsaban G, Kaplan A BMC Med. 2025; 23(1):57.

PMID: 39901232 PMC: 11792534. DOI: 10.1186/s12916-025-03891-9.


The anti-obesity effects of polyphenols: a comprehensive review of molecular mechanisms and signal pathways in regulating adipocytes.

He L, Su Z, Wang S Front Nutr. 2024; 11:1393575.

PMID: 39539361 PMC: 11557335. DOI: 10.3389/fnut.2024.1393575.


Mechanistic Insights into the Biological Effects and Antioxidant Activity of Walnut ( L.) Ellagitannins: A Systematic Review.

Mates L, Banc R, Zaharie F, Rusu M, Popa D Antioxidants (Basel). 2024; 13(8).

PMID: 39199220 PMC: 11351988. DOI: 10.3390/antiox13080974.


References
1.
Kang Y, Jung C, Cho Y, Jang J, Hwang J, Kim E . Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. PLoS One. 2017; 12(6):e0179635. PMC: 5482460. DOI: 10.1371/journal.pone.0179635. View

2.
Navarro E, Funtikova A, Fito M, Schroder H . Can metabolically healthy obesity be explained by diet, genetics, and inflammation?. Mol Nutr Food Res. 2014; 59(1):75-93. DOI: 10.1002/mnfr.201400521. View

3.
Stefan N . Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020; 8(7):616-627. DOI: 10.1016/S2213-8587(20)30110-8. View

4.
Neeland I, Ross R, Despres J, Matsuzawa Y, Yamashita S, Shai I . Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019; 7(9):715-725. DOI: 10.1016/S2213-8587(19)30084-1. View

5.
Despres J . Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012; 126(10):1301-13. DOI: 10.1161/CIRCULATIONAHA.111.067264. View